246 related articles for article (PubMed ID: 31303188)
1. The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms.
Murray LK; Jadavji NM
Nutr Res Rev; 2019 Dec; 32(2):218-230. PubMed ID: 31303188
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
Camicioli RM; Bouchard TP; Somerville MJ
Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
[TBL] [Abstract][Full Text] [Related]
3. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease.
Religa D; Czyzewski K; Styczynska M; Peplonska B; Lokk J; Chodakowska-Zebrowska M; Stepien K; Winblad B; Barcikowska M
Neurosci Lett; 2006 Aug; 404(1-2):56-60. PubMed ID: 16787708
[TBL] [Abstract][Full Text] [Related]
5. Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: A two-sample mendelian randomization study.
Zhao Y; Tian D; Guo N; Zhang C; Zhu R; Liu X; Zhang J
Neurobiol Aging; 2021 Dec; 108():196-199. PubMed ID: 34325950
[TBL] [Abstract][Full Text] [Related]
6. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan.
Murakami K; Miyake Y; Sasaki S; Tanaka K; Fukushima W; Kiyohara C; Tsuboi Y; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
Br J Nutr; 2010 Sep; 104(5):757-64. PubMed ID: 20338075
[TBL] [Abstract][Full Text] [Related]
7. Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients?
Qureshi GA; Qureshi AA; Devrajani BR; Chippa MA; Syed SA
CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):20-7. PubMed ID: 18289028
[TBL] [Abstract][Full Text] [Related]
8. Two Faces of Catechol-O-Methyltransferase Inhibitor on One-Carbon Metabolism in Parkinson's Disease: A Meta-Analysis.
Kim JH; Jin S; Eo H; Oh MS; Lim Y
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839259
[TBL] [Abstract][Full Text] [Related]
9. The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.
Hustad S; Midttun Ø; Schneede J; Vollset SE; Grotmol T; Ueland PM
Am J Hum Genet; 2007 May; 80(5):846-55. PubMed ID: 17436239
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study.
Xu X; Gammon MD; Zhang H; Wetmur JG; Rao M; Teitelbaum SL; Britton JA; Neugut AI; Santella RM; Chen J
Carcinogenesis; 2007 Jul; 28(7):1504-9. PubMed ID: 17372271
[TBL] [Abstract][Full Text] [Related]
11. B-vitamin and choline supplementation increases neuroplasticity and recovery after stroke.
Jadavji NM; Emmerson JT; MacFarlane AJ; Willmore WG; Smith PD
Neurobiol Dis; 2017 Jul; 103():89-100. PubMed ID: 28396257
[TBL] [Abstract][Full Text] [Related]
12. Multiple antioxidants in the prevention and treatment of Parkinson's disease.
Prasad KN; Cole WC; Kumar B
J Am Coll Nutr; 1999 Oct; 18(5):413-23. PubMed ID: 10511322
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine, B-vitamins and CVD.
McNulty H; Pentieva K; Hoey L; Ward M
Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
[TBL] [Abstract][Full Text] [Related]
14. The role of one-carbon metabolism in schizophrenia and depression.
Frankenburg FR
Harv Rev Psychiatry; 2007; 15(4):146-60. PubMed ID: 17687709
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.
Yuan RY; Sheu JJ; Yu JM; Hu CJ; Tseng IJ; Ho CS; Yeh CY; Hung YL; Chiang TR
J Neurol Sci; 2009 Dec; 287(1-2):64-8. PubMed ID: 19786283
[TBL] [Abstract][Full Text] [Related]
16. Associations between B Vitamins and Parkinson's Disease.
Shen L
Nutrients; 2015 Aug; 7(9):7197-208. PubMed ID: 26343714
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.
Hazra A; Wu K; Kraft P; Fuchs CS; Giovannucci EL; Hunter DJ
Carcinogenesis; 2007 Jul; 28(7):1510-9. PubMed ID: 17389618
[TBL] [Abstract][Full Text] [Related]
18. Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.
Andréasson M; Brodin L; Laffita-Mesa JM; Svenningsson P
J Parkinsons Dis; 2017; 7(4):619-628. PubMed ID: 28759974
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.
Zee RY; Mora S; Cheng S; Erlich HA; Lindpaintner K; Rifai N; Buring JE; Ridker PM
Clin Chem; 2007 May; 53(5):845-51. PubMed ID: 17332146
[TBL] [Abstract][Full Text] [Related]
20. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]